PL2539352T3 - Pochodne amp do leczenia chorób serca - Google Patents

Pochodne amp do leczenia chorób serca

Info

Publication number
PL2539352T3
PL2539352T3 PL11713395T PL11713395T PL2539352T3 PL 2539352 T3 PL2539352 T3 PL 2539352T3 PL 11713395 T PL11713395 T PL 11713395T PL 11713395 T PL11713395 T PL 11713395T PL 2539352 T3 PL2539352 T3 PL 2539352T3
Authority
PL
Poland
Prior art keywords
treating cardiac
cardiac diseases
amp derivatives
derivatives
diseases
Prior art date
Application number
PL11713395T
Other languages
English (en)
Inventor
Bruce Liang
Kenneth A. Jacobson
Bhalchandra V. Joshi
Thatikonda Santosh Kumar
Original Assignee
University Of Connecticut
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Connecticut, The United States Of America, As Represented By The Secretary, Department Of Health And Human Services filed Critical University Of Connecticut
Publication of PL2539352T3 publication Critical patent/PL2539352T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11713395T 2010-02-22 2011-02-22 Pochodne amp do leczenia chorób serca PL2539352T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30668710P 2010-02-22 2010-02-22
EP11713395.9A EP2539352B1 (en) 2010-02-22 2011-02-22 Amp derivatives for treating cardiac diseases
PCT/US2011/025680 WO2011103552A2 (en) 2010-02-22 2011-02-22 Compositions and methods to treat cardiac diseases

Publications (1)

Publication Number Publication Date
PL2539352T3 true PL2539352T3 (pl) 2018-03-30

Family

ID=44212109

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11713395T PL2539352T3 (pl) 2010-02-22 2011-02-22 Pochodne amp do leczenia chorób serca

Country Status (11)

Country Link
US (3) US8822434B2 (pl)
EP (1) EP2539352B1 (pl)
CN (1) CN102985432B (pl)
AU (1) AU2011217815B2 (pl)
CA (1) CA2789259C (pl)
DK (1) DK2539352T3 (pl)
ES (1) ES2654363T3 (pl)
HU (1) HUE037611T2 (pl)
PL (1) PL2539352T3 (pl)
PT (1) PT2539352T (pl)
WO (1) WO2011103552A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2539352T3 (en) 2010-02-22 2018-01-08 Univ Connecticut AMP derivatives for the treatment of heart disease
KR102257063B1 (ko) 2016-01-29 2021-05-27 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
WO2017185061A1 (en) 2016-04-21 2017-10-26 Astrocyte Pharmaceuticals, Inc. Compounds and methods for treating neurological and cardiovascular conditions
CN109689636A (zh) 2016-09-14 2019-04-26 株式会社半导体能源研究所 有机化合物、发光元件、发光装置、电子设备及照明装置
KR102701648B1 (ko) 2016-12-28 2024-09-03 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 표시 장치, 및 조명 장치
KR102581109B1 (ko) 2017-05-02 2023-09-21 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
WO2019157317A1 (en) 2018-02-09 2019-08-15 Astrocyte Pharmaceuticals, Inc. Compounds and methods for treating addiction and related disorders
CN112204002A (zh) 2018-05-31 2021-01-08 株式会社半导体能源研究所 有机化合物、发光元件、发光装置、电子设备及照明装置
US12089490B2 (en) 2018-07-31 2024-09-10 Semiconductor Energy Laboratory Co., Ltd. Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device
JP2022502405A (ja) 2018-09-26 2022-01-11 アストロサイト ファーマシューティカルズ, インコーポレイテッド 多形化合物およびその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7348315B2 (en) * 1995-03-23 2008-03-25 The University Of Connecticut Methods of treating heart failure with modified ATP, ADP and AMP compounds
US5712258A (en) * 1995-03-23 1998-01-27 The Trustees Of The University Of Pennsylvania Inotropic ADP and ATP analogues and their pharmaceutical compositions
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
EP1872797A3 (en) * 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
ATE336492T1 (de) 2000-01-14 2006-09-15 Us Gov Health & Human Serv Methonocarbacycloalkylanaloga von nucleosiden
KR20070050484A (ko) 2004-09-09 2007-05-15 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 A1 및 a3 아데노신 수용체 아고니스트로서의 퓨린 유도체
WO2006091905A1 (en) 2005-02-25 2006-08-31 Gilead Sciences, Inc. Bicyclo (3.1.0) hexane derivatives as antiviral compounds
DK2049127T3 (en) * 2006-05-23 2015-01-05 Univ Connecticut N-METHANOCARBA DERIVATIVES FOR TREATMENT OF HEART DISEASES
DK2539352T3 (en) 2010-02-22 2018-01-08 Univ Connecticut AMP derivatives for the treatment of heart disease

Also Published As

Publication number Publication date
HUE037611T2 (hu) 2018-09-28
AU2011217815A1 (en) 2012-10-11
US9303053B2 (en) 2016-04-05
DK2539352T3 (en) 2018-01-08
CA2789259C (en) 2019-08-20
CN102985432A (zh) 2013-03-20
WO2011103552A3 (en) 2012-03-15
US9526739B2 (en) 2016-12-27
WO2011103552A9 (en) 2012-04-26
CA2789259A1 (en) 2011-08-25
US20150038463A1 (en) 2015-02-05
EP2539352B1 (en) 2017-10-04
US20160166591A1 (en) 2016-06-16
ES2654363T3 (es) 2018-02-13
EP2539352A2 (en) 2013-01-02
WO2011103552A2 (en) 2011-08-25
CN102985432B (zh) 2016-11-02
PT2539352T (pt) 2018-01-03
US8822434B2 (en) 2014-09-02
AU2011217815B2 (en) 2015-03-12
US20110212924A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
EP2629736A4 (en) FABRIC TREATMENT
ZA201308417B (en) Tissue healing
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
PL2643004T3 (pl) Kompozycja oligosacharydów do leczenia chorób skóry
IL220876A0 (en) Treatment of cardiac conditions
ZA201301601B (en) Treatment of diseases
PT2539352T (pt) Composições e métodos para tratar doenças cardíacas
EP2613786A4 (en) TREATMENT OF DISEASES
GB2496805B (en) Compounds for photodynamic therapy
EP2621498A4 (en) COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
IL275350B (en) Treatment of neoplastic diseases
HK1204452A1 (en) Treatment for bone diseases
EP2544686A4 (en) COMBINED METHODS FOR THE TREATMENT OF DISEASES
HK1210969A1 (en) Substituted heterocyclic compounds for disease treatment
HK1207579A1 (en) Composition for preventing or treating heart disease
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS
PL392436A1 (pl) Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
IL225755A0 (en) Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain
EP2601954A4 (en) THERAPEUTIC FOR DISEASES
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
HK1208454A1 (zh) 治療細菌性疾病的嘧啶衍生物
ZA201400488B (en) Compounds for the treatment of cancers associated with human papillomavirus
EP2563353A4 (en) COMPOUNDS FOR ANTIFUNGAL TREATMENT
HUE048942T2 (hu) Antraciklin-származékok tumorbetegségek kezeléséhez
GB201016836D0 (en) Composition for skin treatment